Skip to main content
DCGI queries Glenmark Pharma on claims of FabiFlu use for COVID-19 patients with comorbidities - Zee News 20-Jul-2020
DCGI queries Glenmark Pharma on claims of FabiFlu use for COVID-19 patients with comorbidities - Zee News
India s drug regulator DCGI has sought a clarification from Glenmark Pharmaceuticals over its alleged false claims about the use of anti-viral FabiFlu on COVID-19 patients with comorbidities. Also, the pricing of the drug is in question after a Member of …
More...